Correlation Between NextCure and Processa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both NextCure and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NextCure and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NextCure and Processa Pharmaceuticals, you can compare the effects of market volatilities on NextCure and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NextCure with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NextCure and Processa Pharmaceuticals.
Diversification Opportunities for NextCure and Processa Pharmaceuticals
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between NextCure and Processa is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding NextCure and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and NextCure is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NextCure are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of NextCure i.e., NextCure and Processa Pharmaceuticals go up and down completely randomly.
Pair Corralation between NextCure and Processa Pharmaceuticals
Given the investment horizon of 90 days NextCure is expected to generate 0.4 times more return on investment than Processa Pharmaceuticals. However, NextCure is 2.52 times less risky than Processa Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Processa Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 136.00 in NextCure on September 2, 2024 and sell it today you would lose (19.00) from holding NextCure or give up 13.97% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NextCure vs. Processa Pharmaceuticals
Performance |
| Timeline |
| NextCure |
| Processa Pharmaceuticals |
NextCure and Processa Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NextCure and Processa Pharmaceuticals
The main advantage of trading using opposite NextCure and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NextCure position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.| NextCure vs. CytomX Therapeutics | NextCure vs. Spero Therapeutics | NextCure vs. Instil Bio | NextCure vs. Assembly Biosciences |
| Processa Pharmaceuticals vs. Alpha Cognition | Processa Pharmaceuticals vs. Acurx Pharmaceuticals LLC | Processa Pharmaceuticals vs. Fennec Pharmaceuticals | Processa Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| CEOs Directory Screen CEOs from public companies around the world |